Every record from Janoshik · page 6
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041332 | Semaglutide | WWB | WWB-2606-N3192 | 2026-Q3 | 99.66 | 4.72 | 101.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043023 | Semaglutide | KP | KP-2511-J4998 | 2026-Q2 | 99.53 | 8.11 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042914 | Gonadorelin | MKM | MKM-2604-A2596 | 2026-Q2 | 99.93 | 5.19 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042234 | N-Acetyl Semax Amide | Homopeptide | HOMO-2603-C1382 | 2026-Q2 | 98.99 | 8.00 | 99.6 | Supplier-supplied | 0 | PASS |
| AX-2026-041864 | PT-141 (Bremelanotide) | JEEP | JEEP-2601-K3015 | 2026-Q2 | 99.35 | 3.99 | 92.2 | Supplier-supplied | 0 | PASS |
| AX-2026-041461 | Retatrutide | QYB | QYB-2604-B5660 | 2026-Q3 | 99.14 | 2.29 | 97.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043200 | Semaglutide | GL Biochem | GLBI-2602-U8631 | 2026-Q3 | 97.27 | 5.79 | 101.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042467 | Kisspeptin-10 | SWB | SWB-2603-D6238 | 2026-Q3 | 97.97 | 5.39 | — | Laboratory-retained | 4 | FAIL |
| AX-2026-042213 | LL-37 | Homopeptide | HOMO-2602-G1280 | 2026-Q3 | 99.06 | 5.98 | 100.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041959 | Tirzepatide | TFC | TFC-2605-G5134 | 2026-Q3 | 98.69 | 7.22 | 105.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041382 | BPC-157 | WWB | WWB-2606-H3906 | 2026-Q3 | 99.90 | 4.95 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042618 | KPV | GGPeps | GGPE-2511-K8830 | 2026-Q2 | 98.62 | 5.19 | 103.1 | Supplier-supplied | 1 | FAIL |
| AX-2026-042549 | Survodutide | ERP | ERP-2605-E7682 | 2026-Q3 | 98.73 | 5.51 | 91.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042468 | Semaglutide | SWB | SWB-2603-T5632 | 2026-Q2 | 99.17 | 6.49 | 89.8 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-041428 | Ipamorelin | QYB | QYB-2605-H4298 | 2026-Q3 | 99.93 | 3.85 | 106.9 | Supplier-supplied | 2 | FAIL |
| AX-2026-043036 | Retatrutide | KP | KP-2607-H5219 | 2026-Q3 | 95.67 | 5.85 | 94.5 | Buyer-sourced | 2 | FAIL |
| AX-2026-041940 | Semax | TFC | TFC-2602-F4591 | 2026-Q2 | 99.06 | 8.38 | 98.8 | Buyer-sourced | 0 | PASS |
| AX-2026-041518 | Retatrutide | QYB | QYB-2602-R6263 | 2026-Q2 | 97.87 | 5.72 | 101.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043144 | GHK-Cu | SSA | SSA-2604-V7620 | 2026-Q2 | 98.35 | 5.25 | 105.8 | Supplier-supplied | 0 | PASS |
| AX-2026-042026 | Ipamorelin | TFC | TFC-2603-M6766 | 2026-Q2 | 99.93 | 4.85 | 91.9 | Supplier-supplied | 0 | PASS |
| AX-2026-041464 | SS-31 (Elamipretide) | QYB | QYB-2512-H5402 | 2026-Q2 | 99.51 | 4.72 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041309 | Ipamorelin | WWB | WWB-2604-E3153 | 2026-Q2 | 99.93 | 6.14 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042639 | IGF-1 LR3 | GGPeps | GGPE-2604-K8140 | 2026-Q2 | 98.11 | 2.57 | 88.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042218 | LL-37 | Homopeptide | HOMO-2602-G1280 | 2026-Q3 | 99.58 | 5.94 | 104.1 | Supplier-supplied | 0 | PASS |
| AX-2026-041590 | SS-31 (Elamipretide) | QSC | QSC-2605-E6873 | 2026-Q2 | 99.26 | 2.58 | 92.4 | Supplier-supplied | 0 | PASS |
| AX-2026-041261 | Semaglutide | WWB | WWB-2604-J2590 | 2026-Q2 | 99.93 | 7.05 | 99.3 | Supplier-supplied | 0 | PASS |
| AX-2026-042932 | L-Glutathione (reduced) | MKM | MKM-2511-F2902 | 2026-Q2 | 98.57 | 8.41 | 92.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041535 | Retatrutide | QYB | QYB-2602-G6308 | 2026-Q3 | 98.77 | 3.47 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043515 | MGF | BCH | BCH-2511-D7240 | 2026-Q2 | 98.77 | 4.95 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042120 | PT-141 (Bremelanotide) | TFC | TFC-2512-M8211 | 2026-Q2 | 98.71 | 6.46 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042066 | CJC-1295 with DAC | TFC | TFC-2605-P7517 | 2026-Q2 | 98.66 | 6.04 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041807 | Tirzepatide | FGP | FGP-2605-R1831 | 2026-Q2 | 98.11 | 6.47 | 96.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043117 | Mazdutide | SSA | SSA-2605-G6781 | 2026-Q2 | 99.23 | 3.67 | 90.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042550 | GHK-Cu | ERP | ERP-2601-F7633 | 2026-Q2 | 98.53 | 4.43 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042352 | TB-500 | HJ | HJ-2511-L4170 | 2026-Q2 | 99.93 | 2.64 | 100.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041500 | Kisspeptin-10 | QYB | QYB-2512-X5662 | 2026-Q2 | 99.93 | 4.34 | 88.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041394 | Adipotide | WWB | WWB-2512-R4093 | 2026-Q2 | 99.53 | 3.42 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043459 | BPC-157 | WXT | WXT-2602-W4680 | 2026-Q2 | 98.27 | 5.34 | 105.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042692 | Retatrutide | GGPeps | GGPE-2512-D9394 | 2026-Q2 | 98.59 | 3.93 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041443 | Liraglutide | QYB | QYB-2511-V5143 | 2026-Q2 | 99.28 | 6.08 | — | Supplier-supplied | 0 | PASS |